Endocrine Testing Market - Insights
Endocrine testing involves measuring of endocrine hormone concentration in order to diagnose the various disorders such as diabetes, hypothyroidism, infertility, and other hormonal disorder. Endocrine glands secret hormones directly into bloodstream thereby helping in regulation of various body functions such as growth and development, metabolism, reproduction, stimuli response, and homeostasis. Various endocrine glands present in body include pituitary glands, thyroid glands, hypothalamus, pancreas, and adrenal glands. Any imbalance in the hormones secreted by this glands leads to certain disorder therefore they are important marker to diagnose certain condition. Endocrine testing involves testing of the hormones such as insulin, thyroid stimulating hormone, follicle stimulating hormones, human chorionic gonadotropin, progesterone, testosterone, cortisol, prolactin, and other hormones. Various assay kits are used in order to determine the concentration of hormone. It confirms presence of lower than normal or upper than normal range of hormone in blood, thereby indicating the disorder.
The global endocrine testing market was valued at US$ 2.95 billion in 2017, and is expected to witness a CAGR of 4.9% over the forecast period (2018 – 2026).
Figure 1. Global Endocrine Testing Market Value (US$ Mn), by Region, 2017
Increasing prevalence of endocrine disorders to drive growth of the endocrine testing market
Increasing prevalence of endocrinal disorders such as diabetes, hypo/hyperthyroidism, infertility, multiple endocrine neoplasia 1 and 2, hypo/hyperadrenocorticism and hypogonadism are expected to fuel growth of endocrine testing market. Presence of these disease can be confirmed with measurement of blood hormone level to observe imbalance in their concentration. Globally hypothyroidism and hyperthyroidism are one of fastest growing endocrinal disorder. According to American Thyroid Association, in 2017, around 20 million U.S. citizens experience thyroid annually. An estimated around 12% of the U.S. population is expected to suffer from thyroid disease in their lifetime. Moreover, around 60% of people who has thyroid are unaware of their disease. It is common endocrine disorder in emerging economies due to iodine deficiency in diet. According to study published in Indian Journal of Endocrinology and Metabolism (IJEM), thyroid disease in India has incidence of 11% (4-5% for developed countries) and as per epidemiological study published in IJEM in 2011, around 42 million people were affected by the thyroid disorder. Imbalance in sex hormones such as follicle stimulating hormone lead to various disease including infertility condition. According to report by Maternal Health Task Force, in 2017, around 50 million couples experience infertility globally each year. Other endocrinal disease such as Cushing syndrome and gigantism would also see steady prevalence which would present the growth opportunity in endocrine testing market.
New products launched by the key players in test kits are expected to propel growth of endocrine testing market
Companies are launching innovative products to cater the end user need and increase the market footprint in the endocrine testing market. In 2017, Beckman Coulter Diagnostics received FDA clearance of its automated Access AMH immunoassay for in vitro diagnostic (IVD) use. AMH test helps healthcare providers in the assessment of a woman's ovarian reserve, thereby aid in the clinical management of women facing infertility or women planning to become pregnant later in life. The Access AMH assay is a paramagnetic particle chemiluminescent immunoassay for the quantitative determination of AMH levels. The test can be used in conjunction with other clinical and laboratory findings such as antral follicle count, before starting fertility therapy. Companies are also undergoing strategic collaboration to increase market share. For instance, in 2017, Quest diagnostics and Walmart collaborated, under which Quest would open laboratory testing services at 15 Walmart locations initially to gradually increase same.
Key companies covered as a part of this study include Abbott Laboratories, Thermo Fisher Scientific, Beckman Coulter, Inc., Siemens Healthineers, bioMérieux SA, Agilent Technologies, BioRad Laboratories, AB Sciex, F-Hoffmann La Roche AG, Quest Diagnostics, and others.
Endocrine testing procedure consist of measuring concentration of endocrinal hormones in blood or urine. These hormones are precise marker for presence of endocrinal disease such as hypo/hyperthyroidism, infertility etc. Various endocrine glands present in body include pituitary glands, thyroid glands, hypothalamus, pancreas, and adrenal glands. Any imbalance in the hormones secreted by this glands leads to certain disorder therefore they are important marker to diagnose certain condition.
Major factor driving growth of the endocrine testing market is increasing prevalence of endocrinal disease which requires first point diagnosis. Cushing syndrome is one of major endocrinal disorder. Cushing syndrome is result of the excess exposure to hormone cortisol. Cortisol concentration may elevate due to longer treatment of chronic asthma or rheumatoid arthritis and other causes. According to American Association of Neurological Surgeon statistics, around 10-15 per million people are affected by Cushing syndrome every year. Prevalence of postmenopausal osteoporosis is high, owing to low production of estradiol in women. According to International Osteoporosis Foundation factsheet, around 30% of all postmenopausal women have osteoporosis in the US and in Europe. Among them, 40% of women suffer from one or more fragility fractures in their lifetime. Increasing ageing population is also expected to aid in growth of the endocrine testing market, owing to high prevalence of endocrinal disease. According to population Prospect report by United Nations in 2017, an estimated 962 million people are aged 60 or above in the world, which accounted for 13% of the global population. The number of older people in the world is projected to be 1.4 billion growing at annual rate of 3% by 2030.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 45 market data tables and 35 figures on "Endocrine Testing Market - Global forecast to 2026”.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.